Validating α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors
- PMID: 28658304
- PMCID: PMC5489156
- DOI: 10.1371/journal.pone.0178472
Validating α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors
Abstract
Recently, 211At has received increasing attention as a potential radionuclide for cancer radioimmunotherapy. It is a α-particle emitter, which is extremely effective against malignant cells. We demonstrate a method to verify the efficiency of 211At-labeled trastuzumab antibodies (211At-trastuzumab) against HER2 antigens, which has not been determined for radioimmunotherapy. A CR-39 plastic nuclear detector is used for measuring the position and the linear energy transfer (LET) of individual 211At α- particle tracks. The tracks and 211At-trastuzumab-binding cells were co-visualized by using the geometric information recorded on the CR-39. HER2-positive human gastric cancer cells (NCI-N87), labelled with 211At-trastuzumab, were dropped on the centre of the CR-39 plate. Microscope images of the cells and the corresponding α-tracks acquired by position matching were obtained. In addition, 3.5 cm × 3.5 cm macroscopic images of the whole plate were acquired. The distribution of number of α-particles emitted from single cells suggests that 80% of the 211At-trastuzumab-binding cells emitted α-particles. It also indicates that the α-particles may strike the cells several times along their path. The track-averaged LET of the α-particles is evaluated to be 131 keV/μm. These results will enable quantitative evaluation of delivered doses to target cells, and will be useful for the in vitro assessment of 211At-based radioimmunotherapeutic agents.
Conflict of interest statement
Figures





Similar articles
-
Evidence of Local Concentration of α-Particles from 211At-Labeled Antibodies in Liver Metastasis Tissue.J Nucl Med. 2019 Apr;60(4):497-501. doi: 10.2967/jnumed.118.216853. Epub 2018 Oct 5. J Nucl Med. 2019. PMID: 30291193 Free PMC article.
-
Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate.Cancer Res. 1994 Sep 1;54(17):4719-25. Cancer Res. 1994. PMID: 8062270
-
Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.Radiat Res. 2002 Jun;157(6):633-41. doi: 10.1667/0033-7587(2002)157[0633:vtrwta]2.0.co;2. Radiat Res. 2002. PMID: 12005541
-
Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy.Curr Pharm Des. 2000 Sep;6(14):1433-55. doi: 10.2174/1381612003399275. Curr Pharm Des. 2000. PMID: 10903402 Review.
-
Radioimmunotherapy with alpha-particle emitting radioimmunoconjugates.Acta Oncol. 1996;35(3):373-9. doi: 10.3109/02841869609101654. Acta Oncol. 1996. PMID: 8679269 Review.
Cited by
-
Estimation of biological effect of Cu-64 radiopharmaceuticals with Geant4-DNA simulation.Sci Rep. 2022 May 27;12(1):8957. doi: 10.1038/s41598-022-13096-2. Sci Rep. 2022. PMID: 35624130 Free PMC article.
-
Utility of 211At-Trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically Relevant Mouse Model.J Nucl Med. 2021 Oct;62(10):1468-1474. doi: 10.2967/jnumed.120.249300. Epub 2021 Feb 5. J Nucl Med. 2021. PMID: 33547212 Free PMC article.
-
DNA damage response in a 2D-culture model by diffusing alpha-emitters radiation therapy (Alpha-DaRT).Sci Rep. 2024 May 20;14(1):11468. doi: 10.1038/s41598-024-62071-6. Sci Rep. 2024. PMID: 38769339 Free PMC article.
-
Evidence of Local Concentration of α-Particles from 211At-Labeled Antibodies in Liver Metastasis Tissue.J Nucl Med. 2019 Apr;60(4):497-501. doi: 10.2967/jnumed.118.216853. Epub 2018 Oct 5. J Nucl Med. 2019. PMID: 30291193 Free PMC article.
-
Development of an ultrahigh resolution real time alpha particle imaging system for observing the trajectories of alpha particles in a scintillator.Sci Rep. 2023 Apr 26;13(1):4955. doi: 10.1038/s41598-023-31748-9. Sci Rep. 2023. PMID: 37100780 Free PMC article.
References
-
- Newman HC, Prise KM, Folkard M, Michael BD. DNA double-strand break distributions in X-ray and alpha-particle irradiated V79 cells: Evidence for non-random breakage. Int. J. Radiat. Biol. 1997; 71; 347–363. - PubMed
-
- Claesson K, Magnander K, Kahu H, Lindegren S, Hultborn R, Elmroth K. RBE of α-particles from 211At for complex DNA damage and cell survival in relation to cell cycle position. Int. J. Radiat. Biol. 2011; 87; 372–384. doi: 10.3109/09553002.2011.538127 - DOI - PubMed
-
- Raju MR, Eisen Y, Carpenter S, Inkret WC. Radiobiology of α particles III. Cell inactivation by α-particle traversals of the cell nucleus. Radiat Res. 1991; 128: 204–209. - PubMed
-
- Hill A, Herdman MT, Stevens DL, Jones NJ, Thacker J, Goodhead DT. Relative sensitivities of repair-deficient mammalian cells for clonogenic survival after α-Particles irradiation. Radiat Res. 2004; 162: 667–676. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous